| Literature DB >> 29213286 |
Tone Mari Rode1, Anette McLeod2, Ingrid Måge2, Even Heir2, Lars Axelsson2, Askild L Holck2.
Abstract
The ability of foodborne pathogens to exhibit adaptive responses to stressful conditions in foods may enhance their survival when passing through the gastrointestinal system. We aimed to determine whether Escherichia coli surviving stresses encountered during a model dry-fermented sausage (DFS) production process exhibit enhanced tolerance and survival in an in vitro gastrointestinal model. Salami sausage batters spiked with five E. coli isolates, including enterohaemorrhagic E. coli strains isolated from different DFS outbreaks, were fermented in a model DFS process (20°C, 21 days). Control batters spiked with the same strains were stored at 4°C for the same period. Samples from matured model sausages and controls were thereafter exposed to an in vitro digestion challenge. Gastric exposure (pH 3) resulted in considerably reduced survival of the E. coli strains that had undergone the model DFS process. This reduction continued after entering intestinal challenge (pH 8), but growth resumed after 120 min. When subjected to gastric challenge for 120 min, E. coli that had undergone the DFS process showed about 2.3 log10 lower survival compared with those kept in sausage batter at 4°C. Our results indicated that E. coli strains surviving a model DFS process exhibited reduced tolerance to subsequent gastric challenge at low pH.Entities:
Year: 2017 PMID: 29213286 PMCID: PMC5682073 DOI: 10.1155/2017/5176384
Source DB: PubMed Journal: Int J Microbiol
E. coli isolates used in this study.
| Number | Strain | Serotype |
|
| Source | Comments/reference |
|---|---|---|---|---|---|---|
| (1) | E218/02 | O157:H7 | − | + | Dry-fermented sausage | Outbreak Sweden, 2002 |
| (2) | MF3582 | O157:H- | − | + | Human, clinical | Outbreak Norway 2009†, sorbitol positive [ |
| (3) | MF2411 | O111:H- | + | + | Semidry-fermented sausage (mettwurst) | Outbreak Australia, 1995‡ [ |
| (4) | MF2494 | O103:H25 | − | + | Human, clinical | Outbreak Norway 2006§ [ |
| (5) | MF2522 | O103:H25 | − | − | Dry-fermented sausage (morr) | Linked to outbreak in Norway, 2006§ [ |
Kindly received from Dr. S. Löfdahl, Swedish Institute for Infectious Disease Control, Solna, Sweden. †Kindly received from Professor G. Kapperud, Norwegian Institute of Public Health, Oslo, Norway. ‡Kindly received from Dr. F. Scheutz, Statens Serum Institut, Copenhagen, Denmark. §Kindly received from Dr. C. Sekse, Norwegian School of Veterinary Science, Oslo, Norway.
Digestion challenge model treatments.
| Sample | Treatment time (min) | |
|---|---|---|
| Gastric acid | Intestinal fluid | |
| G1 | 1 | 0 |
| G30 | 30 | 0 |
| G30I30 | 30 | 30 |
| G30I120 | 30 | 120 |
| G30I240 | 30 | 240 |
| G120 | 120 | 0 |
| G120I30 | 120 | 30 |
| G120I120 | 120 | 120 |
| G120I240 | 120 | 240 |
Details are described in Materials and Methods. Digestion challenge model. E. coli isolates surviving a TFS production process were exposed to a model mimicking part of the gastrointestinal tract. G: gastric acid treatment and I: intestinal fluid treatment.
Figure 1Flow chart illustrating the experimental setup. TFS (tube fermented sausage) and control batter (15 g) were transferred to separate stomacher bags, diluted 1 : 10 in gastric acid solution, and stomached for 1 min. Samples were transferred to tubes and incubated for 1, 30, and 120 min (samples G1, G30, and G120, resp.). Furthermore, intestinal fluid solution was added to samples after 30 and 120 min (1 : 1). Sampling from G30 and G120 tubes was performed after 30, 120, and 240 min. Each experiment was repeated three times and included 2 sample types (fermented and controls) × 2 parallels × 5 E. coli strains. A total of 60 (3 × 20) samples were included for the digestion challenge study.
Figure 2Reduction of E. coli in a TFS model. Salami batter with starter culture fermented at 20°C for 21 days giving matured sausages (orange bars) and meat batter controls without starter culture held at 4°C (blue bars) are shown. Isolates are numbered according to Table 1.
Figure 3Counts of E. coli during digestion challenge. Salami batter with starter culture fermented at 20°C for 21 days and thereafter stored for 24 h at 4°C (∆) and control batters without starter culture which were held at 4°C for 22 days (○) are shown. Exposure of samples to gastric acid (gastric treatment; G) for 30 or 120 min and subsequently to intestinal fluid (intestinal treatment; I) for 240 min is according to Table 2. Dotted and continuous lines represent samples exposed to 30 and 120 min of gastric treatments, respectively, before intestinal treatment. Average values from three independent experiments with two parallels each are given, and strains are numbered according to Table 1.
Reduction of E. coli during gastric treatment.
| Fermentation status | Strain | Gastric treatment time (min) | ||
|---|---|---|---|---|
| 1 | 30 | 120 | ||
| TFS | (1) | 1.26 (0.20) | 2.03 (0.26) | 2.87 (0.63) |
| (2) | 0.76 (0.30) | 2.12 (0.27) | 2.88 (0.32) | |
| (3) | 1.04 (0.50) | 2.05 (0.60) | 2.56 (0.65) | |
| (4) | 0.88 (0.48) | 2.22 (0.24) | 3.14 (0.14) | |
| (5) | 1.14 (0.35) | 1.84 (0.64) | 3.45 (0.46) | |
| Control | (1) | 0.32 (0.17) | 0.37 (0.16) | 0.71 (0.13) |
| (2) | 0.06 (0.02) | 0.14 (0.09) | 0.49 (0.05) | |
| (3) | 0.13 (0.13) | 0.35 (0.12) | 0.69 (0.24) | |
| (4) | 0.32 (0.08) | 0.38 (0.18) | 0.75 (0.15) | |
| (5) | 0.30 (0.18) | 0.51 (0.31) | 1.02 (0.20) | |
The numbers are average reductions of log10cfu values compared with before gastric treatment. Standard deviation values are shown in brackets.
Reductions of E. coli during intestinal treatment.
| Fermentation status | Strain | Intestinal treatment time after 30 min gastric treatment (min) | Intestinal treatment time after 120 min gastric treatment (min) | ||||
|---|---|---|---|---|---|---|---|
| 30 | 120 | 240 | 30 | 120 | 240 | ||
| TFS | (1) | 0.42 (0.38) | 0.70 (0.26) | −0.33 (0.36) | 0.76 (0.16) | 1.03 (0.79) | 0.18 (0.64) |
| (2) | 0.37 (0.34) | 0.58 (0.22) | −0.91 (0.51) | 1.23 (0.14) | 1.46 (0.16) | 1.00 (0.86) | |
| (3) | 0.41 (0.22) | 0.50 (0.22) | −1.00 (0.18) | 1.05 (0.16) | 0.85 (0.46) | −0.13 (0.35) | |
| (4) | 0.26 (0.38) | 0.40 (0.39) | −0.49 (0.43) | 1.27 (0.53) | 1.23 (0.49) | 0.69 (0.90) | |
| (5) | 0.80 (0.76) | 0.95 (1.35) | −0.01 (1.28) | 1.30 (0.20) | 1.46 (0.30) | 0.79 (0.43) | |
| Control | (1) | 0.25 (0.19) | 0.14 (0.14) | −1.52 (0.28) | 0.18 (0.22) | 0.20 (0.14) | −0.86 (0.34) |
| (2) | 0.18 (0.24) | −0.13 (0.14) | −1.83 (0.09) | 0.22 (0.28) | 0.26 (0.12) | −1.16 (0.55) | |
| (3) | 0.20 (0.20) | 0.03 (0.18) | −1.69 (0.30) | 0.15 (0.42) | 0.33 (0.36) | −0.94 (0.46) | |
| (4) | 0.20 (0.08) | −0.04 (0.09) | −1.84 (0.13) | 0.18 (0.16) | 0.20 (0.10) | −1.32 (0.16) | |
| (5) | 0.21 (0.18) | 0.13 (0.07) | −1.27 (0.44) | 0.54 (0.41) | 0.42 (0.12) | −0.66 (0.49) | |
The numbers are average reductions of log10cfu values compared with after gastric treatment. Standard deviation values are shown in brackets.
ANOVA of E. coli reductions during gastric acid treatment in a TFS model†.
| Source | Degrees of freedom | Explained variance |
|---|---|---|
| Strain ( | 4 | 1.0 |
| Fermentation ( | 1 | 56.3 |
| Gastric acid incubation time ( | 2 | 22.9 |
|
| 4 | 0.1 |
|
| 8 | 1.0 |
|
| 2 | 8.1 |
| Tube (within | 50 | 6.0 |
| Tube × | 100 | 3.8 |
| Error | 8 | 0.7 |
|
| 0.83 |
†Main effects and two-factor interactions are included. The factor tube is modelled as random, while all other factors are considered fixed. Numbers in the table correspond to explained variances (sum-of-squares as % of total sum-of-squares), and significant effects on 1% level are marked by ∗. The model is based on gastric acid treatments for 1, 30, and 120 min (G1, G30, and G120, resp.; Table 2). Other factors are fermentation (4 or 20°C) and strain (E. coli isolates, Table 1).
ANOVA of E. coli reductions during intestinal fluid treatments in a TFS model†.
| Source | Degrees of freedom | Explained variance |
|---|---|---|
| Strain ( | 4 | 2.2 |
| Fermentation ( | 1 | 21.6 |
| Gastric incubation time ( | 1 | 8.3 |
| Intestine incubation time ( | 2 | 35.8 |
|
| 4 | 0.8 |
|
| 4 | 0.7 |
|
| 8 | 0.5 |
|
| 1 | 1.5 |
|
| 2 | 2.7 |
|
| 2 | 1.4 |
| Tube (within | 50 | 8.2 |
| Tube × | 50 | 7.5 |
| Tube × | 100 | 4.7 |
| Error | 130 | 4.1 |
|
| 0.89 |
†Main effects and two-factor interactions are included. The factor tube is modelled as random, while all other factors are considered fixed. Numbers in the table correspond to explained variances (sum-of-squares as % of total sum-of-squares), and significant effects on 1% level are marked by ∗. The model is based on intestinal treatments for 30, 120, and 240 min (I30, I120, and I240, resp.; Table 2) after 30 or 120 min of gastric acid exposure (G30 and G120, resp.; Table 2). Other factors are fermentation (4 or 20°C) and strain (E. coli isolates, Table 1).